Cancer therapy using a combination of a Hsp90 inhibitory compounds and a EGFR inhibitor
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 8, 2015
Grant Date -
Jun 13, 2013
app pub date -
Apr 19, 2011
filing date -
Apr 19, 2010
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A pharmaceutical combination comprising an EGFR inhibitor and an Hsp90 inhibitor according to the following formulae (I) or (Ia) a tautomer, or a pharmaceutically acceptable salt thereof, wherein the variables in the structural formulae are defined herein. Also provided are methods for treating a proliferative disorder in a subject in need thereof using pharmaceutical combinations disclosed herein.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully